Chicago Atlantic BDC (LIEN) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
2 Feb, 2026Executive summary
Entered into a definitive agreement to acquire a $130 million+ loan portfolio from Chicago Atlantic Loan Portfolio, LLC, with closing anticipated in early to mid-Q4 2024, subject to customary conditions.
Net asset value per share was $13.56 as of June 30, 2024, down from $13.77 at December 31, 2023.
Investment portfolio fair value was $53.4 million across six portfolio companies, with $34.0 million in cash and cash equivalents.
The investment strategy was expanded in April 2024 to include companies outside cannabis and health and wellness sectors.
Declared and paid two quarterly dividends of $0.25 per share during the first half of 2024, with another $0.25 dividend approved for Q3 2024.
Financial highlights
Total investment income for Q2 2024 was $3.1 million, with $5.84 million for the six months ended June 30, 2024.
Net investment income for Q2 2024 was $1.5 million ($0.25 per share), with $1.53 million for the six months, impacted by $2.64 million in non-recurring transaction expenses.
Net assets at period end were $84.3 million, with available liquidity of $34.0 million in cash equivalents.
Net increase in net assets from operations was $1.3 million for Q2 2024 and $1.81 million for the six months.
Net realized and unrealized gains for the six months were $0.13 million.
Outlook and guidance
The Loan Portfolio Acquisition is expected to close in early to mid-Q4 2024, significantly increasing the investment portfolio.
The company continues to review a pipeline of $550–560 million in potential investments.
Management noted positive momentum at the state level for cannabis regulatory reform, but regulatory and political uncertainty remains.
A $0.25 per share dividend was approved for Q3 2024, payable September 27, 2024.
Latest events from Chicago Atlantic BDC
- $219.6M loan portfolio acquisition tripled net assets and expanded diversification.LIEN
Q3 202415 Jan 2026 - Cannabis lending offers unique risk-reward and is poised for growth as capital markets evolve.LIEN
Fireside chat13 Jan 2026 - Q4 and FY24 saw portfolio expansion, 36% dividend growth, and a $100M credit facility.LIEN
Q4 202427 Dec 2025 - Annual meeting to vote on board re-election and auditor, with focus on cannabis lending.LIEN
Proxy Filing2 Dec 2025 - Vote on board re-election and auditor ratification at the June 2025 virtual annual meeting.LIEN
Proxy Filing2 Dec 2025 - Annual meeting to vote on director re-election and auditor ratification, with Board support.LIEN
Proxy Filing2 Dec 2025 - $7.6M net investment income, $0.34/share dividend, and $100M credit facility highlight Q1 2025.LIEN
Q1 202525 Nov 2025 - Q2 2025 saw strong income, high yields, and robust liquidity, fueling continued portfolio growth.LIEN
Q2 202523 Nov 2025 - Q3 2025 saw record originations, strong income, high cannabis exposure, and robust liquidity.LIEN
Q3 202517 Nov 2025